Author
Limor Ast, LMFT
2 articles
Dr. Ast is a licensed Psychotherapist and an AAMFT approved supervisor. She has been working in the field of mental health for 19 years. Throughout her extensive career, she has dedicated herself to providing therapeutic services to a diverse range of clients, including children, adolescents, adults, couples, and families within the community.
In addition to her clinical work, Dr. Ast is deeply committed to education and has served as a dedicated academic instructor, teaching graduate students in both Family Therapy and Mental Health Counseling programs.
Dr. Ast is a passionate advocate for human rights and social justice, values that permeate her teaching and therapy practices.
Dr. Ast's psychotherapy and teaching practices are characterized by attitudes of humility, collaboration, and curiosity, creating an enriching and empowering learning environment for her students and fostering holistic well-being for her clients.
When the Record Becomes the Treatment: Psychotherapy, Documentation, and the Clinician’s Double Bind
The 2026 Lindsay Clancy trial has placed mental health treatment under unusually intense public scrutiny. Testimony and cross-examination have raised questions about assessment, diagnosis, medication management, continuity of care, telehealth, documentation, and what clinicians recognized or failed to recognize before a catastrophic outcome. Those questions matter. Yet the case is most useful to the profession […]
Limor Ast, LMFT
October 28, 2026
Beyond the Binary: Challenging American Gender Policies Through Philosophy, Biology, and Cultural History
The rigid binary classifications imposed by the American government on gender and the corresponding policies targeting transgender individuals rest on an outdated and essentialist understanding of sex and identity. These policies, which legislate bodies and identities through restrictive definitions, stand in stark contrast to both contemporary gender theory and a long history of cultural recognition […]
Limor Ast, LMFT
April 21, 2025